BACKGROUND: A small group of children have second and even more cerebrospinal fluid (CSF) shunt infections (SIs). We sought to describe the treatment approaches used for, and the microbiology of, repeated SIs. METHODS: The study population included 31 children with second shunt infection (SI-2) among those undergoing initial CSF shunt placement and treatment for initial infection at Primary Children's Medical Center. CSF SI was defined as follows: (1) presence of bacteria in Gram stain and/or culture of CSF, wound, and/or pseudocyst; (2) visible hardware; (3) abdominal pseudocyst; or (4) presence of bacteria in a blood culture in children with a ventriculoatrial shunt. Infection rates were generated using per-patient denominators, and the concordance of organisms across infections was summarized. RESULTS: Of the 31 children with SI-2, most were less than 6 months of age at initial shunt placement (81%), male (77%), and with ventriculoperitoneal shunts (71%). Of total, 18 developed SI-3 and 8 developed SI-4. Infection rates were 60% (95% confidence interval [CI]: 42%-75%, n = 18/30) for SI-3 and 47% (95% CI: 26%-69%, n = 8/17) for SI-4. The median time to SI-3 was 477 days (range, 5-828) and to SI-4 it was 2137 days (range, 9-2137). Gram-positive organisms predominated (93% of SI-2, 94% of SI-3). The majority of SI-2 demonstrated Gram-stain concordance with both the initial (first) SI (58%, 95% CI: 41%-74%) and with the following (third) SI (78%, 95% CI: 55%-91%). CONCLUSIONS: Children with SI-2 experience high subsequent reinfection rates with a long time to reinfection.
BACKGROUND: A small group of children have second and even more cerebrospinal fluid (CSF) shunt infections (SIs). We sought to describe the treatment approaches used for, and the microbiology of, repeated SIs. METHODS: The study population included 31 children with second shunt infection (SI-2) among those undergoing initial CSF shunt placement and treatment for initial infection at Primary Children's Medical Center. CSF SI was defined as follows: (1) presence of bacteria in Gram stain and/or culture of CSF, wound, and/or pseudocyst; (2) visible hardware; (3) abdominal pseudocyst; or (4) presence of bacteria in a blood culture in children with a ventriculoatrial shunt. Infection rates were generated using per-patient denominators, and the concordance of organisms across infections was summarized. RESULTS: Of the 31 children with SI-2, most were less than 6 months of age at initial shunt placement (81%), male (77%), and with ventriculoperitoneal shunts (71%). Of total, 18 developed SI-3 and 8 developed SI-4. Infection rates were 60% (95% confidence interval [CI]: 42%-75%, n = 18/30) for SI-3 and 47% (95% CI: 26%-69%, n = 8/17) for SI-4. The median time to SI-3 was 477 days (range, 5-828) and to SI-4 it was 2137 days (range, 9-2137). Gram-positive organisms predominated (93% of SI-2, 94% of SI-3). The majority of SI-2 demonstrated Gram-stain concordance with both the initial (first) SI (58%, 95% CI: 41%-74%) and with the following (third) SI (78%, 95% CI: 55%-91%). CONCLUSIONS:Children with SI-2 experience high subsequent reinfection rates with a long time to reinfection.
Authors: J Kestle; J Drake; R Milner; C Sainte-Rose; G Cinalli; F Boop; J Piatt; S Haines; S Schiff; D Cochrane; P Steinbok; N MacNeil Journal: Pediatr Neurosurg Date: 2000-11 Impact factor: 1.162
Authors: John R W Kestle; Jay Riva-Cambrin; John C Wellons; Abhaya V Kulkarni; William E Whitehead; Marion L Walker; W Jerry Oakes; James M Drake; Thomas G Luerssen; Tamara D Simon; Richard Holubkov Journal: J Neurosurg Pediatr Date: 2011-07 Impact factor: 2.375
Authors: Tamara D Simon; Matthew Hall; J Michael Dean; John R W Kestle; Jay Riva-Cambrin Journal: J Neurosurg Pediatr Date: 2010-09 Impact factor: 2.375
Authors: M H Samore; M K Magill; S C Alder; E Severina; L Morrison-De Boer; J L Lyon; K Carroll; J Leary; M B Stone; D Bradford; J Reading; A Tomasz; M A Sande Journal: Pediatrics Date: 2001-10 Impact factor: 7.124
Authors: Tamara D Simon; Matthew Hall; Jay Riva-Cambrin; J Elaine Albert; Howard E Jeffries; Bonnie Lafleur; J Michael Dean; John R W Kestle Journal: J Neurosurg Pediatr Date: 2009-08 Impact factor: 2.375
Authors: Matthew J McGirt; Aimee Zaas; Herbert E Fuchs; Timothy M George; Keith Kaye; Daniel J Sexton Journal: Clin Infect Dis Date: 2003-03-18 Impact factor: 9.079
Authors: Tamara D Simon; Nicole Mayer-Hamblett; Kathryn B Whitlock; Marcie Langley; John R W Kestle; Jay Riva-Cambrin; Margaret Rosenfeld; Emily A Thorell Journal: J Pediatric Infect Dis Soc Date: 2013-08-26 Impact factor: 3.164
Authors: Tamara D Simon; Kathryn B Whitlock; Jay Riva-Cambrin; John R W Kestle; Margaret Rosenfeld; J Michael Dean; Richard Holubkov; Marcie Langley; Nicole Mayer-Hamblett Journal: J Neurosurg Pediatr Date: 2012-01 Impact factor: 2.375
Authors: Tamara D Simon; Brian Van Yserloo; Kevin Nelson; David Gillespie; Randy Jensen; James P McAllister; Jay Riva-Cambrin; Chris Stockmann; Judy A Daly; Anne J Blaschke Journal: Diagn Microbiol Infect Dis Date: 2013-08-13 Impact factor: 2.803
Authors: Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman Journal: J Pediatr Date: 2018-12-06 Impact factor: 4.406
Authors: Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle Journal: J Neurosurg Pediatr Date: 2018-02-02 Impact factor: 2.375
Authors: Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy Gove; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; Nicole Mayer-Hamblett Journal: J Pediatr Date: 2016-09-28 Impact factor: 4.406
Authors: Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Samuel R Browd; Richard Holubkov; John R W Kestle; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis N Shannon; Mandeep Tamber; John C Wellons Iii; William E Whitehead; Nicole Mayer-Hamblett Journal: J Pediatric Infect Dis Soc Date: 2019-07-01 Impact factor: 3.164